E-cigarette or vaping use-associated lung injury
Abstract
Over the past decade, the rapid growth in popularity of electronic nicotine delivery systems has led to an increase in lung injury cases and a new condition known as e-cigarette or vaping use-associated lung injury (EVALI).
The aim
of this study was to present the first case of e-cigaretteassociated lung injury reported in a hospital setting.
Results
. A young patient was admitted to the hospital on an emergency basis with severe respiratory complaints. Initial radiographic findings were normal. Over the course of one year, the patient developed progressive respiratory failure, leading to widespread pneumofibrosis, which ultimately resulted in death.
Conclusion
. Based on the identified combination of emphysema, pulmonary fibrosis, and histologically confirmed alveolitis, along with a history of e-cigarette smoking, a diagnosis of toxic acute lung injury (EVALI syndrome) with a histological pattern of diffuse alveolar damage, resulting in pulmonary fibrosis, was verified.
Read the paper
Related studies
- Tobacco and COPD: presenting the World Health Organization (WHO) Tobacco Knowledge Summary
- Comparative effects of e-cigarette smoking on periodontal status, salivary pH, and cotinine levels
- Association between exposure to environmental pollutants and increased oral health risks, a comprehensive review
- Influence of gestational window on offspring vascular health in rodents with in utero exposure to electronic cigarettes
- Natural products as kinase inhibitors in lung cancer: molecular mechanisms, therapeutic potential, and clinical trials
- Nicotine in electronic cigarettes
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.